enzastaurin has been researched along with Waldenstrom Macroglobulinemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghobrial, IM; Roccaro, AM; Sacco, A | 1 |
| Benhadji, KA; Ghobrial, IM; Harris, B; Hossain, AM; Jourdan, E; Leblond, V; Maisonneuve, H; Moreau, P; Nguyen, TS; Poon, T; Wooldridge, JE | 1 |
| Alsayed, Y; Anderson, KC; Daley, J; Ghobrial, IM; Hatjiharissi, E; Hideshima, T; Jia, X; Kutok, J; Lazo-Kallanian, S; Leleu, X; Leontovich, A; Moreau, AS; Ngo, HT; O'Sullivan, G; Podar, K; Raab, MS; Treon, SP; Xu, L | 1 |
1 review(s) available for enzastaurin and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Anti-angiogenic therapies in the treatment of Waldenstrom's Macroglobulinemia.
Topics: Angiogenesis Inhibitors; Bone Marrow; Boronic Acids; Bortezomib; Endothelial Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Panobinostat; Protease Inhibitors; Proteasome Inhibitors; Protein Kinase C; Pyrazines; TOR Serine-Threonine Kinases; Tumor Microenvironment; Waldenstrom Macroglobulinemia | 2011 |
1 trial(s) available for enzastaurin and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Immunoglobulin M; Indoles; Male; Middle Aged; Translational Research, Biomedical; Treatment Outcome; Waldenstrom Macroglobulinemia | 2012 |
1 other study(ies) available for enzastaurin and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia.
Topics: Antigens, CD19; Antineoplastic Agents; Biopsy; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; In Vitro Techniques; Indoles; Inhibitory Concentration 50; Leukocytes, Mononuclear; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Protein Kinase C beta; Time Factors; Waldenstrom Macroglobulinemia | 2007 |